Havas Health, BrightInsight Partner on Adherence

- Medication non-adherence contributes to an estimated $100 billion to $300 billion in avoidable annual healthcare costs in the U.S. from factors like increased hospitalizations and emergency room visits. This significant financial burden is a primary driver for partnerships aiming to improve patient persistence with prescribed treatments. - BrightInsight's underlying platform, built on Google Cloud, is designed for regulated digital health solutions and can integrate with over 400 medical devices, various Electronic Health Record (EHR) systems, and offers pre-built functionalities like medication management and patient-reported outcomes. This technical foundation allows for the aggregation of disparate health data to create personalized patient support programs. - AI is a key component in modern adherence solutions, with machine learning models used to predict which patients are at high risk of stopping their medication by analyzing factors like age, socioeconomic status, and prescription refill patterns. This allows for proactive, personalized interventions, a significant step beyond simple pill reminders. - For consumer health startups, user acquisition strategies employed by successful apps like Noom include leveraging affiliate and influencer marketing to build trust and a heavy investment in paid social and search ads with a sophisticated, psychology-based onboarding quiz. Retention strategies used by apps like Headspace focus on personalized onboarding, gamification with rewards, and timely push notifications to build habit loops, which led to a 109% uplift in week-one retention in one case. - Many consumer health apps, especially those for wellness or fitness tracking, are not covered by HIPAA because they collect data directly from the user rather than on behalf of a healthcare provider. This places the onus on startups to build user trust through transparent privacy policies, as they may instead be governed by the FTC Health Breach Notification Rule and various state privacy laws. - Chronic illness communities express significant "data tracking fatigue" and frustration with apps that focus on logging symptoms without providing actionable insights or correlations, such as how diet or weather might impact their condition. Patients are often concerned about data privacy and how their information might be used by insurers or employers, indicating a need for tools that prioritize user control and clear data ownership. - The digital health fundraising market saw a significant rebound in 2025, with U.S. startups raising $14.2 billion, a 35% increase from 2024. Investment was heavily concentrated, with AI-enabled companies securing 54% of all funding and commanding a 19% premium on average deal size, signaling strong investor confidence in AI-driven healthcare solutions. - The "biohacking" and longevity space, a key interest area for wellness-focused consumers, is moving towards mainstream adoption with a market expected to hit $63 billion by 2028. Current trends for 2025 and 2026 include AI-driven personalized nutrition based on genetic and microbiome data, advanced wearables that track biomarkers like blood glucose and cortisol in real-time, and a focus on senolytics—drugs that target and eliminate aging cells.